XALOX RTU oxaliplatin 50mg/10mL concentrated solution for injection vial

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

oxaliplatin, Quantity: 50 mg

Commercializzato da:

Medis Pharma Pty Ltd

INN (Nome Internazionale):

Oxaliplatin

Forma farmaceutica:

Injection, concentrated

Composizione:

Excipient Ingredients: lactose monohydrate; water for injections

Via di somministrazione:

Intravenous Infusion

Confezione:

1 vial

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: ,? Adjuvant treatment of stage III (Duke?s C) colon cancer after complete resection of ,the primary tumour ,? Treatment of advanced colorectal cancer

Dettagli prodotto:

Visual Identification: Clear, colourless to slightly yellow solution.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2011-12-12